share_log

Canopy Growth | S-1: General form for registration of securities under the Securities Act of 1933

Canopy Growth | S-1:证券上市注册声明

SEC announcement ·  01/26 06:48
Moomoo AI 已提取核心信息
Canopy Growth Corporation, a leading cannabis and consumer packaged goods company, has filed a Form S-1 registration statement with the U.S. Securities and Exchange Commission (SEC) on January 26, 2024. The filing pertains to the registration of 16,317,020 common shares for resale, which includes shares issued in a private placement on January 19, 2024, and shares underlying Series A and Series B Warrants. The private placement involved the issuance of 8,158,510 units at a price of US$4.29 per unit, each consisting of one common share and one warrant. The Series A Warrants are exercisable at US$4.83 per share and have different exercise periods compared to the Series B Warrants. Canopy Growth will not receive proceeds from the resale of shares by the selling securityholders but could receive approximately US$39.4 million upon full cash exercise of the warrants, which would be used for working capital and other corporate purposes. The common shares are traded on the Toronto Stock Exchange and the Nasdaq Global Select Market under the symbols 'WEED' and 'CGC' respectively.
Canopy Growth Corporation, a leading cannabis and consumer packaged goods company, has filed a Form S-1 registration statement with the U.S. Securities and Exchange Commission (SEC) on January 26, 2024. The filing pertains to the registration of 16,317,020 common shares for resale, which includes shares issued in a private placement on January 19, 2024, and shares underlying Series A and Series B Warrants. The private placement involved the issuance of 8,158,510 units at a price of US$4.29 per unit, each consisting of one common share and one warrant. The Series A Warrants are exercisable at US$4.83 per share and have different exercise periods compared to the Series B Warrants. Canopy Growth will not receive proceeds from the resale of shares by the selling securityholders but could receive approximately US$39.4 million upon full cash exercise of the warrants, which would be used for working capital and other corporate purposes. The common shares are traded on the Toronto Stock Exchange and the Nasdaq Global Select Market under the symbols 'WEED' and 'CGC' respectively.
领先的大麻和消费品包装公司Canopy Growth Corporation已于2024年1月26日向美国证券交易委员会(SEC)提交了S-1表格注册声明。该文件涉及16,317,020股普通股的转售登记,其中包括2024年1月19日私募发行的股票以及A系列和B系列认股权证的标的股份。此次私募涉及以每单位4.29美元的价格发行8,158,510个单位,每股包括一股普通股和一份认股权证。A系列认股权证的行使价格为每股4.83美元,与B系列认股权证的行使期不同。Canopy Growth不会获得出售证券持有人转售股票的收益,但在行使认股权证的全额现金后可能获得约3,940万美元,用于营运资金和其他公司用途。普通股在多伦多证券交易所和纳斯达克全球精选市场上市,股票代码分别为 “WEED” 和 “CGC”。
领先的大麻和消费品包装公司Canopy Growth Corporation已于2024年1月26日向美国证券交易委员会(SEC)提交了S-1表格注册声明。该文件涉及16,317,020股普通股的转售登记,其中包括2024年1月19日私募发行的股票以及A系列和B系列认股权证的标的股份。此次私募涉及以每单位4.29美元的价格发行8,158,510个单位,每股包括一股普通股和一份认股权证。A系列认股权证的行使价格为每股4.83美元,与B系列认股权证的行使期不同。Canopy Growth不会获得出售证券持有人转售股票的收益,但在行使认股权证的全额现金后可能获得约3,940万美元,用于营运资金和其他公司用途。普通股在多伦多证券交易所和纳斯达克全球精选市场上市,股票代码分别为 “WEED” 和 “CGC”。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息